glp-1-based therapy Can GLP-1 Medications Affect Athletic Performance and Recovery? GLP-1-based therapies for diabetes, obesity

By Mick Foley GLP-1 receptor agonists are a class of medications primarily used to manage type 2 diabetes mellitus

This combination creates a double risk for B12 deficiency, as both medications can impair absorption through different mechanisms

This pattern has been documented in clinical settings and is not unique to GLP-1 weight loss, but can occur with any significant metabolic or nutritional change

Ozempic: Primarily for type 2 diabetes, administered via subcutaneous injection

Benefits of non-surgical skin tightening Tightens mild to moderately loose skin on the face, neck, or body without surgery or scars Many treatments can provide a noticeable lifting effect Little to no downtime is needed Very low risk of adverse effects when performed by a qualified provider Treatments can be performed in-office, typically in 1 hour or less Results can last up to 1 year Limitations Results appear gradually over several weeks or months following treatment Multiple treatments may be needed to achieve desired results Treatment will need to be repeated periodically to maintain results Not effective on more advanced skin sagging, such as pronounced jowling or stretched skin following pregnancy or weight loss Am I a good candidate for non-surgical skin tightening

Medical education initiatives enhance physician training in obesity pharmacotherapy management and patient selection criteria